Instead of wasting money on aducanumab, pay for programs proven to help people living with dementia-Reference-Cited by-同舟云学术

Instead of wasting money on aducanumab, pay for programs proven to help people living with dementia

Published:2021-09-16 Issue:12 Volume:69 Page:3690-3692
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Hunt Lauren J.¹²^ORCID,Harrison Krista L.²³⁴^ORCID,Covinsky Kenneth E.⁴

Affiliation:

1. Department of Physiological Nursing University of California, San Francisco San Francisco California USA

2. Global Brain Health Institute University of California, San Francisco San Francisco California USA

3. Division of Geriatrics University of California, San Francisco San Francisco California USA

4. Philip R. Lee Institute for Health Policy Studies University of California, San Francisco San Francisco California USA

Funder

National Center for Advancing Translational Sciences

National Institute on Aging

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17462

Reference20 articles.

1. Food and Drug AdministrationNovember 6 2020 BLA 761178: Peripheral and Central Nervous System Drugs Advisory Committee Meeting. Accessed September 9 2021.https://www.fda.gov/media/143505/download

2. Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab

3. Prescribing aducanumab in the face of meager efficacy and real risks;Knopman DS;Neurology,2021

4. Aducanumab for Alzheimer’s disease?

5. GrahamJ.Paying billions for controversial Alzheimer's drug? How about funding this instead? Kaiser Health News. Accessed September 9 2021.https://khn.org/news/article/paying-billions-for-controversial-alzheimers-drug-how-about-funding-this-instead/

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal anti‐amyloid antibodies for the treatment of Alzheimer's disease and the hesitant geriatrician;Journal of the American Geriatrics Society;2023-11

2. Prediction of misfolded proteins spreading in Alzheimer’s disease using machine learning and spreading models;Cerebral Cortex;2023-10-13

3. Care Setting Transitions for People With Dementia: Qualitative Perspectives of Current and Former Care Partners;American Journal of Hospice and Palliative Medicine®;2023-02-02

4. A low-dimensional cognitive-network space in Alzheimer’s disease and frontotemporal dementia;Alzheimer's Research & Therapy;2022-12-29

5. High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects;Revue Neurologique;2022-12